Head of Global Marketing at GW Pharmaceuticals

Strategic commercial development of GW’s cannabinoid portfolio including pre-clinical drug candidate assessment

Commercial planning lead for the launch of Epidiolex® USA and EU

Led GW’s International Business Development with a focus on orphan disease indications

Oversight of Vimpat® at UCB, with >$1bn sales